Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation

Nat Commun. 2024 Apr 8;15(1):3016. doi: 10.1038/s41467-024-46547-7.

Abstract

Myelodysplastic syndromes (MDS) with mutated SF3B1 gene present features including a favourable outcome distinct from MDS with mutations in other splicing factor genes SRSF2 or U2AF1. Molecular bases of these divergences are poorly understood. Here we find that SF3B1-mutated MDS show reduced R-loop formation predominating in gene bodies associated with intron retention reduction, not found in U2AF1- or SRSF2-mutated MDS. Compared to erythroblasts from SRSF2- or U2AF1-mutated patients, SF3B1-mutated erythroblasts exhibit augmented DNA synthesis, accelerated replication forks, and single-stranded DNA exposure upon differentiation. Importantly, histone deacetylase inhibition using vorinostat restores R-loop formation, slows down DNA replication forks and improves SF3B1-mutated erythroblast differentiation. In conclusion, loss of R-loops with associated DNA replication stress represents a hallmark of SF3B1-mutated MDS ineffective erythropoiesis, which could be used as a therapeutic target.

MeSH terms

  • Humans
  • Mutation
  • Myelodysplastic Syndromes* / drug therapy
  • Myelodysplastic Syndromes* / genetics
  • Phosphoproteins / genetics
  • R-Loop Structures*
  • RNA Splicing Factors / genetics
  • Serine-Arginine Splicing Factors / genetics
  • Splicing Factor U2AF / genetics
  • Transcription Factors / genetics

Substances

  • Splicing Factor U2AF
  • Serine-Arginine Splicing Factors
  • RNA Splicing Factors
  • Transcription Factors
  • Phosphoproteins
  • SF3B1 protein, human